A new lease on life for dendritic cell vaccines?

Nature Biotechnology

Volumn 24, Issue 12, 2006, Pages 1483-1484

  Nestle, Frank O ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; ONCOLOGY; VACCINES;

CANCER VACCINES; DENDRITIC CELL VACCINES; DENDRITIC CELLS;

BIOTECHNOLOGY;

CANCER VACCINE; DENDRITIC CELL VACCINE; PLACEBO; PROTEIN KINASE B;

CELL MATURATION; CELL SURVIVAL; CLINICAL TRIAL; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY; TUMOR IMMUNITY; TUMOR REGRESSION; VACCINATION;

CANCER VACCINES; CELL DIFFERENTIATION; CELL SURVIVAL; CLINICAL TRIALS, PHASE III; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 33845689520     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1206-1483     Document Type: Short Survey

References (12)

1. Nestle, F.O., Banchereau, J. & Hart, D. Nat. Med. 7, 761-765 (2001).
2. Park, D., Lapteva, N., Seethammagari, M., Slawin, K.M. & Spencer, D.M. Nat. Biotechnol. 24, 1581-1590 (2006).
3. Banchereau, J. & Steinman, R.M. Nature 392, 245-252 (1998).
4. Reis e Sousa, C. Nat. Rev. Immunol. 6, 476-483 (2006).
5. Schadendorf, D. et al. Ann. Oncol. 17, 563-570 (2006).
6. Small, E.J. et al. J. Clin. Oncol. 24, 3089-3094 (2006).
7. Srivastava, P.K. Curr. Opin. Immunol. 18, 201-205 (2006).
8. Josien, R. et al. J. Exp. Med. 191, 495-502 (2000).
9. Lowy, D.R. & Schiller, J.T. J. Clin. Invest. 116, 1167-1173 (2006).
10. Boon, T., Coulie, P.G., Van den Eynde, B.J. & van der Bruggen, P. Annu. Rev. Immunol. 24, 175-208 (2006).
11. Peggs, K.S., Quezada, S.A., Korman, A.J. & Allison, J.P. Curr. Opin. Immunol. 18, 206-213 (2006).
12. Pulendran, B. & Ahmed, R. Cell 124, 849-863 (2006).